<unk>  is a HMG-CoA reductase inhibitor that is FDA approved for the treatment of hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia, secondary prevention of cardiovascular disease.   Common adverse reactions include indigestion, nausea, headache.
Fluvastatin
Simvastatin
Mevastatin
Ezetimibe
Lovastatin
Atorvastatin
Cholestyramine
Clofibrate